Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Tian, Qing E ^a,b   De Li, Huan ^a   Yan, Miao ^a   Cai, Hua Lin ^a   Tan, Qin You ^a   Zhang, Wen Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Xiangtan Central Hospital   (China)

Author keywords

Astragalus polysaccharides; Multidrug resistance; P glycoprotein

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; POLYSACCHARIDE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HEPATOMA CELL; IC 50; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84863579262     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-94     Document Type: Article

References (49)

1. Lancet T. Moving cancer up the global health agenda. Lancet 2010, 375(9731):2051. 10.1016/S0140-6736(10)60942-7, 20542154.
2. The World Health Report 2008 - primary health care: Now more than ever http://www.who.int/whr/2008/whr08_en.pdf.
3. Urruticoechea A, Alemany R, Balart J, Villanueva A, Viñals F, Capellá G. Recent advances in cancer therapy: an overview. Curr Pharm Des 2010, 16(1):3-10. 10.2174/138161210789941847, 20214614.
4. Kellof GJ. Perspective on cancer chemoprevention research and drug development. Adv Cancer Res 2000, 78:199-334.
5. Choi CH. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 2005, 5:30. 10.1186/1475-2867-5-30, 1277830, 16202168.
6. Nobili S, Landini I, Giglioni B, Mini E. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 2006, 7(7):861-879. 10.2174/138945006777709593, 16842217.
7. Wong R, Sagar CM, Sagar SM. Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition. Cancer Treat Rev 2001, 27(4):235-246. 10.1053/ctrv.2001.0227, 11545543.
8. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK, Tang W. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 2010, 4(6):297-307.
9. Ruan WJ, Lai MD, Zhou JG. Anticancer effects of Chinese herbal medicine, science or myth?. J Zhejiang Univ Sci B 2006, 7(12):1006-1014. 10.1631/jzus.2006.B1006, 1661669, 17111471.
10. Konkimalla VB, Efferth T. Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol 2008, 116(2):207-210. 10.1016/j.jep.2007.12.009, 18243610.
11. Ji DB, Ye J, Jiang YM, Qian BW. Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing mice. BMC Complement Altern Med 2009, 9:20. 10.1186/1472-6882-9-20, 2720913, 19570195.
12. Balch PA. Prescription for Nutritional Healing, A Practical A-to-Z Reference to Drug-Free Remedies Using Vitamins, Minerals, Herbs and Food Supplements 2006, New York, NY, USA: Avery Penguin Putnam Inc., 5.
13. Rittenhouse JR, Lui PD, Lau BH. Chinese medicinal herbs reverse macrophage suppression induced by urological tumors. J Urol 1991, 146(2):486-490.
14. Ma XQ, Shi Q, Duan JA, Dong TT, Tsim KW. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agric Food Chem 2002, 50(17):4861-4866. 10.1021/jf0202279, 12166972.
15. Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun 2004, 320(4):1103-1111. 10.1016/j.bbrc.2004.06.065, 15249203.
16. Li J, Bao Y, Lam W, Li W, Lu F, Zhu X, Liu J, Wang H. Immunoregulatory and anti-tumor effects of polysaccharopeptide and Astragalus polysaccharides on tumor-bearing mice. Immunopharmacol Immunotoxicol 2008, 30(4):771-782. 10.1080/08923970802279183, 18686097.
17. Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. J Gastroenterol Hepatol 2010, 25(2):420-426. 10.1111/j.1440-1746.2009.05981.x, 19793165.
18. Zhao LH, Ma ZX, Zhu J, Yu XH, Weng DP. Characterization of polysaccharide from Astragalus radix as the macrophage stimulator. Cell Immunol 2011, 271(2):329-334. 10.1016/j.cellimm.2011.07.011, 21937031.
19. World Health Organization (WHO) Medicinal Plants in China 1989, Manila: WHO Regional Publications, World Health Organization (WHO).
20. Zee-Cheng RK. Shi-quan-da-bu-tang (ten signifcant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Methods Find Exp Clin Pharmacol 1992, 14(9):725-736.
21. Cui R, He J, Wang B, Zhang F, Chen G, Yin S, Shen H. Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol 2003, 51(1):75-80. 10.1007/s00280-002-0532-5, 12497209.
22. Wang J, Ito H, Shimura K. Enhancing effect of antitumor polysaccharide from Astragalus or Radix hedysarum on C3 cleavage production of macrophages in mice. Jpn J Pharmacol 1989, 51(3):432-434. 10.1254/jjp.51.432, 2622096.
23. Guo L, Bai SP, Zhao L, Wang XH. Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival. Med Oncol http://dx.doi.org/10.1007/s12032-011-0068-9.
24. Liu XN, Zhang CY, Jin XD, Li YZ, Zheng XZ, Li L. Inhibitory effect of schisandrin B on gastric cancer cells in vitro. World J Gastroenterol 2007, 13(48):6506-6511. 10.3748/wjg.13.6506, 18161920.
25. Xu JH, Deng WL, Fan ZZ. Effects of changwelqing on nuclear translocation of Y-box binding protein-1 and expregslon of P-glycoprotein in human colon cancer cell line with drug-resistance induced by vincristine. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010, 30(7):743-747.
26. An HJ, Wang XY, Yu M, Sheng J, Li PT, Zhang B. Influence of preventing formula for UC on P-gp level in colon tissue of ulcerative colitis in rats. Journal of TCM Univ. of Hunan 2009, 29(4):15-17.
27. Huang CH, Xie ZX, Qin Q. The mechanism of Chinese medicine compound jiexinkang to reverse the multidrug resistance of K562/A02 cells. Journal of TCM Univ. of Hunan 2004, 24(1):7-10.
28. Zhang G, Shi L, Selke M, Wang X. CdTe quantum dots with daunorubicin induce apoptosis of multidrug-resistant human hepatoma HepG2/ADM cells: in vitro and in vivo evaluation. Nanoscale Res Lett 2011, 6(1):418. 10.1186/1556-276X-6-418, 3211514, 21711951.
29. Zhou RF, Liu PX, Tan M. Effect of Astragalus mongholicus injection on proliferation and apoptosis of hormone sensitive (MCF-7) breast cancer cell lines with physiological dose E2. Zhong Yao Cai 2009, 32(5):744-747.
30. Li Q, Bao JM, Li XL, Zhang T, Shen XH. Inhibiting effect of Astragalus polysaccharides on the functions of CD4 + CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma. Chin Med J (Engl) 2012, 125(5):786-793.
31. Yang M, Qian XH, Zhao DH, Fu SZ. Effects of Astragalus polysaccharide on the erythroid lineage and microarray analysis in K562 cells. J Ethnopharmacol 2010, 127(2):242-250. 10.1016/j.jep.2009.11.013, 19922785.
32. Collett A, Tanianis-Hughes J, Warhurst G. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?. Biochem Pharmacol 2004, 68(4):783-790. 10.1016/j.bcp.2004.05.006, 15276086.
33. Mi Y, Lou L. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. Br J Cancer 2007, 97(7):934-940. 10.1038/sj.bjc.6603985, 2360411, 17912240.
34. Cassileth BR, Rizvi N, Deng G, Yeung KS, Vickers A, Guillen S, Woo D, Coleton M, Kris MG. Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients. Cancer Chemother Pharmacol 2009, 65(1):67-71. 10.1007/s00280-009-1003-z, 19421753.
35. Duan P, Wang ZM. Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002, 22(7):515-517.
36. Zou YH, Liu XM. Effect of astragalus injection combined with chemotherapy on quality of life in patients with advanced non-small cell lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003, 23(10):733-735.
37. Zhang ZX, Qi F, Zhou DJ, Liang XY, Zhu LW, Wang PZ. Effect of 5-fluorouracil in combination with Astragalus membranaceus on amino acid metabolism in mice model of gastric carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 2006, 9(5):445-447.
38. Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 2007, 252(1):43-54. 10.1016/j.canlet.2006.12.001, 17223259.
39. Boyed MR. The NCI in vitro anticancer drug discovery screen. Anticancer drug development guide; preclinical screening, clinical trials and approval 1997, 30. Totowa: Humana Press, Teicher B.
40. Dizdarevic S, Peters AM. Imaging of multidrug resistance in cancer. Cancer Imaging 2011, 11:1-8. 10.1102/1470-7330.2011.0001, 21362586.
41. Goda K, Bacsó Z, Szabó G. Multidrug resistance through the spectacle of P-glycoprotein. Curr Cancer Drug Targets 2009, 9(3):281-297. 10.2174/156800909788166493, 19442049.
42. Mayur YC, Peters GJ, Prasad VV, Lemo C, Sathish NK. Design of new drug molecules to be used in reversing multidrug resistance in cancer cells. Curr Cancer Drug Targets 2009, 9(3):298-306. 10.2174/156800909788166619, 19442050.
43. Li H, Yan Z, Ning W, Xiao-Juan G, Cai-Hong Z, Jin-Hua J, Fang M, Qing-Duan W. Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo. J Biomed Biotechnol 2011, 2011:281651. 3134191, 21765632.
44. Abuznait AH, Patrick SG, Kaddoumi A. Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity. J Pharm Pharm Sci 2011, 14(2):236-248. 3172709, 21733412.
45. Kawami M, Yumoto R, Nagai J, Junyaprasert VB, Soonthornchareonnon N, Patanasethanont D, Sripanidkulchai BO, Takano M. Effect of Thai plant extracts on P-glycoprotein function and viability in paclitaxel-resistant HepG2 cells. Drug Metab Pharmacokinet 2010, 25(2):155-162. 10.2133/dmpk.25.155, 20460821.
46. Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M. Pharmacokinetic interaction of cytochromeP450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Drug Metab Dispos 2001, 29(2):145-151.
47. Naud J, Michaud J, Leblond FA, Lefrancois S, Bonnardeaux A, Pichette V. Effects of chronic renal failure on liver drug transporters. Drug Metab Dispos 2008, 36(1):124-128.
48. Nie L, Wu G, Zhang W. Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: a quantitative analysis. Genetics 2006, 174(4):2229-2243. 10.1534/genetics.106.065862, 1698625, 17028312.
49. Gong J, Jaiswal R, Mathys JM, Combes V, Grau GE, Bebawy M. Microparticles and their emerging role in cancer multidrug resistance. Cancer Treat Rev 2012, 38(3):226-234. 10.1016/j.ctrv.2011.06.005, 21757296.